Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023

Upgrades

For Algonquin Power & Utilities Corp (NYSE:AQN), Wells Fargo upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, Algonquin Power showed an EPS of $0.11, compared to $0.15 from the year-ago quarter. The current stock performance of Algonquin Power shows a 52-week-high of $16.01 and a 52-week-low of $6.41. Moreover, at the end of the last trading period, the closing price was at $6.86.

For FirstCash Holdings Inc (NASDAQ:FCFS), Stephens & Co. upgraded the previous rating of Equal-Weight to Overweight. FirstCash Hldgs earned $1.30 in the third quarter, compared to $0.84 in the year-ago quarter. The stock has a 52-week-high of $100.00 and a 52-week-low of $58.30. At the end of the last trading period, FirstCash Hldgs closed at $86.70.

Truist Securities upgraded the previous rating for Charter Communications Inc (NASDAQ:CHTR) from Hold to Buy. Charter Communications earned $7.38 in the third quarter, compared to $6.50 in the year-ago quarter. The stock has a 52-week-high of $653.09 and a 52-week-low of $297.66. At the end of the last trading period, Charter Communications closed at $354.00.

Jefferies upgraded the previous rating for Check Point Software Technologies Ltd (NASDAQ:CHKP) from Hold to Buy. Check Point Software earned $1.77 in the third quarter, compared to $1.65 in the year-ago quarter. The current stock performance of Check Point Software shows a 52-week-high of $149.62 and a 52-week-low of $107.54. Moreover, at the end of the last trading period, the closing price was at $127.20.

For DocuSign Inc (NASDAQ:DOCU), Jefferies upgraded the previous rating of Hold to Buy. DocuSign earned $0.57 in the third quarter, compared to $0.58 in the year-ago quarter. The current stock performance of DocuSign shows a 52-week-high of $156.41 and a 52-week-low of $39.57. Moreover, at the end of the last trading period, the closing price was at $56.27.

According to Jefferies, the prior rating for Atlassian Corp (NASDAQ:TEAM) was changed from Hold to Buy. Atlassian earned $0.36 in the first quarter, compared to $0.46 in the year-ago quarter. The stock has a 52-week-high of $352.92 and a 52-week-low of $113.86. At the end of the last trading period, Atlassian closed at $126.40.

For Oracle Corp (NYSE:ORCL), Jefferies upgraded the previous rating of Hold to Buy. For the second quarter, Oracle had an EPS of $1.21, compared to year-ago quarter EPS of $1.21. The current stock performance of Oracle shows a 52-week-high of $89.58 and a 52-week-low of $60.78. Moreover, at the end of the last trading period, the closing price was at $84.48.

According to Argus Research, the prior rating for Delta Air Lines Inc (NYSE:DAL) was changed from Hold to Buy. Delta Air Lines earned $1.51 in the third quarter, compared to $0.30 in the year-ago quarter. The current stock performance of Delta Air Lines shows a 52-week-high of $46.27 and a 52-week-low of $27.20. Moreover, at the end of the last trading period, the closing price was at $34.39.

For Olin Corp (NYSE:OLN), Barclays upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, Olin showed an EPS of $2.18, compared to $2.38 from the year-ago quarter. The stock has a 52-week-high of $67.25 and a 52-week-low of $41.33. At the end of the last trading period, Olin closed at $53.29.

Raymond James upgraded the previous rating for Zimmer Biomet Holdings Inc (NYSE:ZBH) from Market Perform to Outperform. In the third quarter, Zimmer Biomet Holdings showed an EPS of $1.58, compared to $1.81 from the year-ago quarter. At the moment, the stock has a 52-week-high of $135.05 and a 52-week-low of $100.39. Zimmer Biomet Holdings closed at $128.46 at the end of the last trading period.

Truist Securities upgraded the previous rating for Silgan Holdings Inc (NYSE:SLGN) from Hold to Buy. In the third quarter, Silgan Hldgs showed an EPS of $1.27, compared to $1.02 from the year-ago quarter. The stock has a 52-week-high of $54.59 and a 52-week-low of $38.59. At the end of the last trading period, Silgan Hldgs closed at $51.58.

Truist Securities upgraded the previous rating for Comcast Corp (NASDAQ:CMCSA) from Hold to Buy. Comcast earned $0.96 in the third quarter, compared to $0.87 in the year-ago quarter. At the moment, the stock has a 52-week-high of $52.10 and a 52-week-low of $28.39. Comcast closed at $36.59 at the end of the last trading period.

Stephens & Co. upgraded the previous rating for Bread Financial Holdings Inc (NYSE:BFH) from Equal-Weight to Overweight. In the third quarter, Bread Financial Holdings showed an EPS of $2.69, compared to $4.47 from the year-ago quarter. At the moment, the stock has a 52-week-high of $60.79 and a 52-week-low of $28.85. Bread Financial Holdings closed at $40.11 at the end of the last trading period.

Barclays upgraded the previous rating for US Foods Holding Corp (NYSE:USFD) from Equal-Weight to Overweight. For the third quarter, US Foods Hldg had an EPS of $0.60, compared to year-ago quarter EPS of $0.48. The stock has a 52-week-high of $39.73 and a 52-week-low of $25.49. At the end of the last trading period, US Foods Hldg closed at $34.78.

Goldman Sachs upgraded the previous rating for First Republic Bank (NYSE:FRC) from Neutral to Buy. For the third quarter, First Republic Bank had an EPS of $2.21, compared to year-ago quarter EPS of $1.91. The current stock performance of First Republic Bank shows a 52-week-high of $209.30 and a 52-week-low of $106.86. Moreover, at the end of the last trading period, the closing price was at $123.79.

B of A Securities upgraded the previous rating for Cullen/Frost Bankers Inc (NYSE:CFR) from Neutral to Buy. Cullen/Frost Bankers earned $2.59 in the third quarter, compared to $1.65 in the year-ago quarter. At the moment, the stock has a 52-week-high of $160.60 and a 52-week-low of $112.67. Cullen/Frost Bankers closed at $131.03 at the end of the last trading period.

According to B of A Securities, the prior rating for FibroGen Inc (NASDAQ:FGEN) was changed from Neutral to Buy. FibroGen earned $0.98 in the third quarter, compared to $0.54 in the year-ago quarter. At the moment, the stock has a 52-week-high of $18.31 and a 52-week-low of $7.81. FibroGen closed at $16.10 at the end of the last trading period.

For Reinsurance Group of America Inc (NYSE:RGA), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. For the third quarter, Reinsurance Group had an EPS of $5.20, compared to year-ago quarter EPS of $1.11. The current stock performance of Reinsurance Group shows a 52-week-high of $148.75 and a 52-week-low of $97.61. Moreover, at the end of the last trading period, the closing price was at $142.03.

According to B of A Securities, the prior rating for The Interpublic Group of Companies Inc (NYSE:IPG) was changed from Underperform to Neutral. For the third quarter, Interpublic Gr of Cos had an EPS of $0.63, compared to year-ago quarter EPS of $0.60. At the moment, the stock has a 52-week-high of $39.98 and a 52-week-low of $25.14. Interpublic Gr of Cos closed at $34.70 at the end of the last trading period.

Credit Suisse upgraded the previous rating for CME Group Inc (NASDAQ:CME) from Neutral to Outperform. CME Group earned $1.98 in the third quarter, compared to $1.60 in the year-ago quarter. The stock has a 52-week-high of $256.94 and a 52-week-low of $166.54. At the end of the last trading period, CME Group closed at $170.08.

For Cboe Global Markets Inc (BATS:CBOE), Credit Suisse upgraded the previous rating of Neutral to Outperform. For the third quarter, Cboe Global Markets had an EPS of $1.74, compared to year-ago quarter EPS of $1.45. At the moment, the stock has a 52-week-high of $130.54 and a 52-week-low of $103.82. Cboe Global Markets closed at $124.47 at the end of the last trading period.

See all analyst ratings upgrades.

Downgrades

Seaport Global downgraded the previous rating for American States Water Co (NYSE:AWR) from Buy to Neutral. American States Water earned $0.69 in the third quarter, compared to $0.76 in the year-ago quarter. The stock has a 52-week-high of $102.89 and a 52-week-low of $71.22. At the end of the last trading period, American States Water closed at $96.25.

For SJW Group (NYSE:SJW), Seaport Global downgraded the previous rating of Buy to Neutral. In the third quarter, SJW Gr showed an EPS of $0.82, compared to $0.64 from the year-ago quarter. The current stock performance of SJW Gr shows a 52-week-high of $83.88 and a 52-week-low of $55.73. Moreover, at the end of the last trading period, the closing price was at $83.35.

Jefferies downgraded the previous rating for Palantir Technologies Inc (NYSE:PLTR) from Buy to Hold. For the third quarter, Palantir Technologies had an EPS of $0.01, compared to year-ago quarter EPS of $0.04. The stock has a 52-week-high of $18.84 and a 52-week-low of $5.92. At the end of the last trading period, Palantir Technologies closed at $6.58.

According to Loop Capital, the prior rating for Armstrong World Industries Inc (NYSE:AWI) was changed from Buy to Hold. In the third quarter, Armstrong World Indus showed an EPS of $1.36, compared to $1.17 from the year-ago quarter. The current stock performance of Armstrong World Indus shows a 52-week-high of $117.64 and a 52-week-low of $66.86. Moreover, at the end of the last trading period, the closing price was at $70.40.

For Dropbox Inc (NASDAQ:DBX), Jefferies downgraded the previous rating of Buy to Hold. For the third quarter, Dropbox had an EPS of $0.43, compared to year-ago quarter EPS of $0.37. The current stock performance of Dropbox shows a 52-week-high of $25.80 and a 52-week-low of $19.07. Moreover, at the end of the last trading period, the closing price was at $22.81.

Jefferies downgraded the previous rating for Vertex Inc (NASDAQ:VERX) from Buy to Hold. In the third quarter, Vertex showed an EPS of $0.08, compared to $0.08 from the year-ago quarter. At the moment, the stock has a 52-week-high of $19.30 and a 52-week-low of $9.44. Vertex closed at $14.76 at the end of the last trading period.

For Verint Systems Inc (NASDAQ:VRNT), Jefferies downgraded the previous rating of Buy to Hold. Verint Systems earned $0.69 in the third quarter, compared to $0.69 in the year-ago quarter. The stock has a 52-week-high of $56.39 and a 52-week-low of $31.63. At the end of the last trading period, Verint Systems closed at $37.08.

Jefferies downgraded the previous rating for Varonis Systems Inc (NASDAQ:VRNS) from Buy to Hold. For the third quarter, Varonis Systems had an EPS of $0.05, compared to year-ago quarter EPS of $0.05. At the moment, the stock has a 52-week-high of $51.60 and a 52-week-low of $15.61. Varonis Systems closed at $24.45 at the end of the last trading period.

According to Jefferies, the prior rating for Five9 Inc (NASDAQ:FIVN) was changed from Buy to Hold. Five9 earned $0.39 in the third quarter, compared to $0.28 in the year-ago quarter. The current stock performance of Five9 shows a 52-week-high of $144.24 and a 52-week-low of $46.61. Moreover, at the end of the last trading period, the closing price was at $69.24.

For CrowdStrike Holdings Inc (NASDAQ:CRWD), Jefferies downgraded the previous rating of Buy to Hold. CrowdStrike Holdings earned $0.40 in the third quarter, compared to $0.17 in the year-ago quarter. The current stock performance of CrowdStrike Holdings shows a 52-week-high of $242.00 and a 52-week-low of $98.70. Moreover, at the end of the last trading period, the closing price was at $104.36.

For Shopify Inc (NYSE:SHOP), Jefferies downgraded the previous rating of Buy to Hold. For the third quarter, Shopify had an EPS of $0.02, compared to year-ago quarter EPS of $0.08. At the moment, the stock has a 52-week-high of $1370.00 and a 52-week-low of $23.63. Shopify closed at $37.54 at the end of the last trading period.

UBS downgraded the previous rating for Gap Inc (NYSE:GPS) from Neutral to Sell. In the third quarter, Gap showed an EPS of $0.71, compared to $0.27 from the year-ago quarter. The stock has a 52-week-high of $19.06 and a 52-week-low of $7.79. At the end of the last trading period, Gap closed at $11.78.

For Ally Financial Inc (NYSE:ALLY), B of A Securities downgraded the previous rating of Buy to Underperform. For the third quarter, Ally Financial had an EPS of $1.12, compared to year-ago quarter EPS of $2.16. The current stock performance of Ally Financial shows a 52-week-high of $53.83 and a 52-week-low of $22.34. Moreover, at the end of the last trading period, the closing price was at $25.24.

According to Argus Research, the prior rating for CarMax Inc (NYSE:KMX) was changed from Buy to Hold. For the third quarter, CarMax had an EPS of $0.24, compared to year-ago quarter EPS of $1.53. The stock has a 52-week-high of $129.05 and a 52-week-low of $52.10. At the end of the last trading period, CarMax closed at $65.12.

According to UBS, the prior rating for Victoria's Secret & Co (NYSE:VSCO) was changed from Neutral to Sell. In the third quarter, Victoria's Secret showed an EPS of $0.29, compared to $0.81 from the year-ago quarter. The current stock performance of Victoria's Secret shows a 52-week-high of $65.20 and a 52-week-low of $26.14. Moreover, at the end of the last trading period, the closing price was at $34.21.

According to Wells Fargo, the prior rating for Delek US Holdings Inc (NYSE:DK) was changed from Overweight to Underweight. In the third quarter, Delek US Hldgs showed an EPS of $0.02, compared to $0.13 from the year-ago quarter. The current stock performance of Delek US Hldgs shows a 52-week-high of $35.45 and a 52-week-low of $14.71. Moreover, at the end of the last trading period, the closing price was at $25.64.

For The Wendy's Co (NASDAQ:WEN), Oppenheimer downgraded the previous rating of Outperform to Perform. Wendy's earned $0.24 in the third quarter, compared to $0.19 in the year-ago quarter. The current stock performance of Wendy's shows a 52-week-high of $24.48 and a 52-week-low of $15.77. Moreover, at the end of the last trading period, the closing price was at $22.82.

For Progyny Inc (NASDAQ:PGNY), SVB Leerink downgraded the previous rating of Outperform to Market Perform. In the third quarter, Progyny showed an EPS of $0.13, compared to $0.17 from the year-ago quarter. At the moment, the stock has a 52-week-high of $53.10 and a 52-week-low of $25.67. Progyny closed at $31.13 at the end of the last trading period.

For Qualys Inc (NASDAQ:QLYS), Needham downgraded the previous rating of Buy to Hold. For the third quarter, Qualys had an EPS of $0.94, compared to year-ago quarter EPS of $0.86. At the moment, the stock has a 52-week-high of $162.36 and a 52-week-low of $107.69. Qualys closed at $112.09 at the end of the last trading period.

According to Raymond James, the prior rating for Veritex Holdings Inc (NASDAQ:VBTX) was changed from Outperform to Market Perform. In the third quarter, Veritex Holdings showed an EPS of $0.80, compared to $0.70 from the year-ago quarter. The current stock performance of Veritex Holdings shows a 52-week-high of $43.33 and a 52-week-low of $26.14. Moreover, at the end of the last trading period, the closing price was at $28.08.

Raymond James downgraded the previous rating for CrossFirst Bankshares Inc (NASDAQ:CFB) from Outperform to Market Perform. For the third quarter, CrossFirst Bankshares had an EPS of $0.35, compared to year-ago quarter EPS of $0.41. The current stock performance of CrossFirst Bankshares shows a 52-week-high of $16.50 and a 52-week-low of $12.17. Moreover, at the end of the last trading period, the closing price was at $12.43.

Raymond James downgraded the previous rating for Business First Bancshares Inc (NASDAQ:BFST) from Outperform to Market Perform. Business First Bancshares earned $0.72 in the third quarter, compared to $0.53 in the year-ago quarter. The current stock performance of Business First Bancshares shows a 52-week-high of $29.50 and a 52-week-low of $20.19. Moreover, at the end of the last trading period, the closing price was at $21.83.

According to Raymond James, the prior rating for Baxter International Inc (NYSE:BAX) was changed from Outperform to Market Perform. In the third quarter, Baxter Intl showed an EPS of $0.82, compared to $1.02 from the year-ago quarter. The stock has a 52-week-high of $89.70 and a 52-week-low of $49.00. At the end of the last trading period, Baxter Intl closed at $52.33.

For Berry Global Group Inc (NYSE:BERY), Truist Securities downgraded the previous rating of Buy to Hold. In the fourth quarter, Berry Global Gr showed an EPS of $2.19, compared to $1.55 from the year-ago quarter. The stock has a 52-week-high of $74.73 and a 52-week-low of $44.52. At the end of the last trading period, Berry Global Gr closed at $61.52.

Stephens & Co. downgraded the previous rating for American Express Co (NYSE:AXP) from Equal-Weight to Underweight. For the third quarter, American Express had an EPS of $2.47, compared to year-ago quarter EPS of $2.27. The stock has a 52-week-high of $199.55 and a 52-week-low of $130.65. At the end of the last trading period, American Express closed at $150.54.

Truist Securities downgraded the previous rating for Sealed Air Corp (NYSE:SEE) from Buy to Hold. Sealed Air earned $0.98 in the third quarter, compared to $0.86 in the year-ago quarter. The current stock performance of Sealed Air shows a 52-week-high of $70.72 and a 52-week-low of $41.24. Moreover, at the end of the last trading period, the closing price was at $51.07.

According to Piper Sandler, the prior rating for Revolve Group Inc (NYSE:RVLV) was changed from Overweight to Neutral. In the third quarter, Revolve Gr showed an EPS of $0.16, compared to $0.22 from the year-ago quarter. The current stock performance of Revolve Gr shows a 52-week-high of $63.92 and a 52-week-low of $20.17. Moreover, at the end of the last trading period, the closing price was at $23.41.

For Nordstrom Inc (NYSE:JWN), Piper Sandler downgraded the previous rating of Overweight to Neutral. Nordstrom earned $0.20 in the third quarter, compared to $0.39 in the year-ago quarter. At the moment, the stock has a 52-week-high of $29.59 and a 52-week-low of $15.53. Nordstrom closed at $16.62 at the end of the last trading period.

Stephens & Co. downgraded the previous rating for Capital One Financial Corp (NYSE:COF) from Equal-Weight to Underweight. Capital One Financial earned $4.20 in the third quarter, compared to $6.86 in the year-ago quarter. The stock has a 52-week-high of $162.40 and a 52-week-low of $86.98. At the end of the last trading period, Capital One Financial closed at $95.80.

Piper Sandler downgraded the previous rating for Allbirds Inc (NASDAQ:BIRD) from Overweight to Neutral. In the third quarter, Allbirds showed an EPS of $0.15, compared to $0.25 from the year-ago quarter. The current stock performance of Allbirds shows a 52-week-high of $16.78 and a 52-week-low of $2.14. Moreover, at the end of the last trading period, the closing price was at $2.42.

According to Goldman Sachs, the prior rating for Essent Group Ltd (NYSE:ESNT) was changed from Buy to Neutral. For the third quarter, Essent Gr had an EPS of $1.66, compared to year-ago quarter EPS of $1.84. The stock has a 52-week-high of $50.17 and a 52-week-low of $34.27. At the end of the last trading period, Essent Gr closed at $39.51.

For Dorian LPG Ltd (NYSE:LPG), UBS downgraded the previous rating of Buy to Neutral. In the second quarter, Dorian LPG showed an EPS of $0.43, compared to $0.25 from the year-ago quarter. The current stock performance of Dorian LPG shows a 52-week-high of $21.07 and a 52-week-low of $10.77. Moreover, at the end of the last trading period, the closing price was at $17.46.

For Y-mAbs Therapeutics Inc (NASDAQ:YMAB), Cowen & Co. downgraded the previous rating of Outperform to Market Perform. Y-mAbs Therapeutics earned $0.63 in the third quarter, compared to $0.66 in the year-ago quarter. At the moment, the stock has a 52-week-high of $20.48 and a 52-week-low of $2.94. Y-mAbs Therapeutics closed at $5.11 at the end of the last trading period.

Cowen & Co. downgraded the previous rating for C.H. Robinson Worldwide Inc (NASDAQ:CHRW) from Outperform to Market Perform. For the third quarter, C.H. Robinson Worldwide had an EPS of $1.78, compared to year-ago quarter EPS of $1.85. The stock has a 52-week-high of $121.23 and a 52-week-low of $86.57. At the end of the last trading period, C.H. Robinson Worldwide closed at $90.80.

Cowen & Co. downgraded the previous rating for Coinbase Global Inc (NASDAQ:COIN) from Outperform to Market Perform. Coinbase Global earned $2.43 in the third quarter, compared to $1.62 in the year-ago quarter. At the moment, the stock has a 52-week-high of $258.81 and a 52-week-low of $31.83. Coinbase Global closed at $37.70 at the end of the last trading period.

UBS downgraded the previous rating for Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) from Buy to Neutral. For the third quarter, Maravai LifeSciences had an EPS of $0.37, compared to year-ago quarter EPS of $0.44. At the moment, the stock has a 52-week-high of $41.82 and a 52-week-low of $12.16. Maravai LifeSciences closed at $13.98 at the end of the last trading period.

According to B of A Securities, the prior rating for Applied Molecular Transport Inc (NASDAQ:AMTI) was changed from Buy to Underperform. Applied Molecular earned $0.65 in the third quarter, compared to $0.68 in the year-ago quarter. At the moment, the stock has a 52-week-high of $13.94 and a 52-week-low of $0.33. Applied Molecular closed at $0.48 at the end of the last trading period.

For EPAM Systems Inc (NYSE:EPAM), Wolfe Research downgraded the previous rating of Outperform to Peer Perform. In the third quarter, EPAM Sys showed an EPS of $3.10, compared to $2.42 from the year-ago quarter. At the moment, the stock has a 52-week-high of $646.16 and a 52-week-low of $168.59. EPAM Sys closed at $335.22 at the end of the last trading period.

B of A Securities downgraded the previous rating for PNC Financial Services Group Inc (NYSE:PNC) from Neutral to Underperform. PNC Financial Services Gr earned $3.78 in the third quarter, compared to $3.75 in the year-ago quarter. The current stock performance of PNC Financial Services Gr shows a 52-week-high of $228.14 and a 52-week-low of $143.52. Moreover, at the end of the last trading period, the closing price was at $163.73.

For Cognizant Technology Solutions Corp (NASDAQ:CTSH), Wolfe Research downgraded the previous rating of Peer Perform to Underperform. For the third quarter, Cognizant Tech Solns had an EPS of $1.17, compared to year-ago quarter EPS of $1.06. At the moment, the stock has a 52-week-high of $93.47 and a 52-week-low of $51.33. Cognizant Tech Solns closed at $58.06 at the end of the last trading period.

For Nomad Foods Ltd (NYSE:NOMD), Credit Suisse downgraded the previous rating of Outperform to Neutral. In the third quarter, Nomad Foods showed an EPS of $0.52, compared to $0.41 from the year-ago quarter. At the moment, the stock has a 52-week-high of $26.89 and a 52-week-low of $12.50. Nomad Foods closed at $17.94 at the end of the last trading period.

For Danaher Corp (NYSE:DHR), Credit Suisse downgraded the previous rating of Outperform to Neutral. Danaher earned $2.56 in the third quarter, compared to $2.39 in the year-ago quarter. The stock has a 52-week-high of $316.04 and a 52-week-low of $233.71. At the end of the last trading period, Danaher closed at $266.37.

Baird downgraded the previous rating for IAA Inc (NYSE:IAA) from Outperform to Neutral. In the third quarter, IAA showed an EPS of $0.45, compared to $0.52 from the year-ago quarter. At the moment, the stock has a 52-week-high of $51.12 and a 52-week-low of $31.32. IAA closed at $40.01 at the end of the last trading period.

Wolfe Research downgraded the previous rating for Cano Health Inc (NYSE:CANO) from Outperform to Peer Perform. For the third quarter, Cano Health had an EPS of $0.23, compared to year-ago quarter EPS of $0.14. At the moment, the stock has a 52-week-high of $9.75 and a 52-week-low of $0.98. Cano Health closed at $1.16 at the end of the last trading period.

For The AZEK Co Inc (NYSE:AZEK), UBS downgraded the previous rating of Buy to Neutral. In the fourth quarter, AZEK Co showed an EPS of $0.16, compared to $0.32 from the year-ago quarter. At the moment, the stock has a 52-week-high of $46.56 and a 52-week-low of $15.12. AZEK Co closed at $22.48 at the end of the last trading period.

Piper Sandler downgraded the previous rating for Wolverine World Wide Inc (NYSE:WWW) from Overweight to Neutral. For the third quarter, Wolverine World Wide had an EPS of $0.48, compared to year-ago quarter EPS of $0.62. The stock has a 52-week-high of $29.30 and a 52-week-low of $9.60. At the end of the last trading period, Wolverine World Wide closed at $11.56.

See all analyst ratings downgrades.

Initiations

With a Hold rating, Craig-Hallum initiated coverage on Tempo Automation Holdings Inc (NASDAQ:TMPO). The price target seems to have been set at $1.00 for Tempo Automation Holdings. The stock has a 52-week-high of $15.15 and a 52-week-low of $0.70. At the end of the last trading period, Tempo Automation Holdings closed at $0.78.

Canaccord Genuity initiated coverage on R1 RCM Inc (NASDAQ:RCM) with a Buy rating. The price target for R1 RCM is set to $14.00. In the third quarter, R1 RCM showed an EPS of $0.07, compared to $0.05 from the year-ago quarter. The current stock performance of R1 RCM shows a 52-week-high of $27.86 and a 52-week-low of $6.71. Moreover, at the end of the last trading period, the closing price was at $11.03.

Wolfe Research initiated coverage on Etsy Inc (NASDAQ:ETSY) with a Peer Perform rating. In the third quarter, Etsy showed an EPS of $0.58, compared to $0.62 from the year-ago quarter. The current stock performance of Etsy shows a 52-week-high of $207.39 and a 52-week-low of $67.01. Moreover, at the end of the last trading period, the closing price was at $117.11.

With a Buy rating, B of A Securities initiated coverage on Amylyx Pharmaceuticals Inc (NASDAQ:AMLX). The price target seems to have been set at $50.00 for Amylyx Pharma. At the moment, the stock has a 52-week-high of $39.77 and a 52-week-low of $6.51. Amylyx Pharma closed at $35.54 at the end of the last trading period.

Wolfe Research initiated coverage on Squarespace Inc (NYSE:SQSP) with a Peer Perform rating. For the third quarter, Squarespace had an EPS of $0.07, compared to year-ago quarter EPS of $0.02. At the moment, the stock has a 52-week-high of $34.97 and a 52-week-low of $14.43. Squarespace closed at $21.48 at the end of the last trading period.

Benchmark initiated coverage on Bragg Gaming Group Inc (NASDAQ:BRAG) with a Speculative Buy rating. The price target for Bragg Gaming Group is set to $8.00. Bragg Gaming Group earned $0.09 in the third quarter, compared to $0.14 in the year-ago quarter. The current stock performance of Bragg Gaming Group shows a 52-week-high of $7.98 and a 52-week-low of $2.30. Moreover, at the end of the last trading period, the closing price was at $4.08.

BMO Capital initiated coverage on AstraZeneca PLC (NASDAQ:AZN) with an Outperform rating. The price target for AstraZeneca is set to $82.00. For the third quarter, AstraZeneca had an EPS of $0.84, compared to year-ago quarter EPS of $1.07. The stock has a 52-week-high of $71.70 and a 52-week-low of $52.65. At the end of the last trading period, AstraZeneca closed at $69.50.

With an Outperform rating, BMO Capital initiated coverage on Foghorn Therapeutics Inc (NASDAQ:FHTX). The price target seems to have been set at $20.00 for Foghorn Therapeutics. In the third quarter, Foghorn Therapeutics showed an EPS of $0.62, compared to $0.71 from the year-ago quarter. At the moment, the stock has a 52-week-high of $22.73 and a 52-week-low of $5.32. Foghorn Therapeutics closed at $6.53 at the end of the last trading period.

B. Riley Securities initiated coverage on Reservoir Media Inc (NASDAQ:RSVR) with a Buy rating. The price target for Reservoir Media is set to $11.00. Reservoir Media earned $0.07 in the second quarter, compared to $0.08 in the year-ago quarter. At the moment, the stock has a 52-week-high of $10.84 and a 52-week-low of $4.42. Reservoir Media closed at $6.05 at the end of the last trading period.

With a Neutral rating, Piper Sandler initiated coverage on Axsome Therapeutics Inc (NASDAQ:AXSM). The price target seems to have been set at $75.00 for Axsome Therapeutics. For the third quarter, Axsome Therapeutics had an EPS of $1.07, compared to year-ago quarter EPS of $0.93. The stock has a 52-week-high of $82.00 and a 52-week-low of $20.63. At the end of the last trading period, Axsome Therapeutics closed at $73.34.

With an Overweight rating, Piper Sandler initiated coverage on Karuna Therapeutics Inc (NASDAQ:KRTX). The price target seems to have been set at $285.00 for Karuna Therapeutics. For the third quarter, Karuna Therapeutics had an EPS of $2.38, compared to year-ago quarter EPS of $1.72. At the moment, the stock has a 52-week-high of $278.25 and a 52-week-low of $92.26. Karuna Therapeutics closed at $198.46 at the end of the last trading period.

Scotiabank initiated coverage on Guardant Health Inc (NASDAQ:GH) with a Sector Outperform rating. The price target for Guardant Health is set to $36.00. In the third quarter, Guardant Health showed an EPS of $1.18, compared to $0.70 from the year-ago quarter. The current stock performance of Guardant Health shows a 52-week-high of $102.85 and a 52-week-low of $24.63. Moreover, at the end of the last trading period, the closing price was at $26.70.

Scotiabank initiated coverage on Illumina Inc (NASDAQ:ILMN) with a Sector Perform rating. The price target for Illumina is set to $216.00. In the third quarter, Illumina showed an EPS of $0.34, compared to $1.45 from the year-ago quarter. The current stock performance of Illumina shows a 52-week-high of $428.00 and a 52-week-low of $173.45. Moreover, at the end of the last trading period, the closing price was at $202.61.

With a Sector Outperform rating, Scotiabank initiated coverage on Veracyte Inc (NASDAQ:VCYT). The price target seems to have been set at $33.00 for Veracyte. In the third quarter, Veracyte showed an EPS of $0.12, compared to $0.20 from the year-ago quarter. At the moment, the stock has a 52-week-high of $42.43 and a 52-week-low of $14.85. Veracyte closed at $23.77 at the end of the last trading period.

With a Sector Outperform rating, Scotiabank initiated coverage on Twist Bioscience Corp (NASDAQ:TWST). The price target seems to have been set at $33.00 for Twist Bioscience. Twist Bioscience earned $0.99 in the fourth quarter, compared to $0.84 in the year-ago quarter. The stock has a 52-week-high of $84.63 and a 52-week-low of $21.78. At the end of the last trading period, Twist Bioscience closed at $25.41.

Scotiabank initiated coverage on Adaptive Biotechnologies Corp (NASDAQ:ADPT) with a Sector Outperform rating. The price target for Adaptive Biotechnologies is set to $15.00. In the third quarter, Adaptive Biotechnologies showed an EPS of $0.32, compared to $0.40 from the year-ago quarter. At the moment, the stock has a 52-week-high of $28.72 and a 52-week-low of $5.96. Adaptive Biotechnologies closed at $8.01 at the end of the last trading period.

With a Sector Outperform rating, Scotiabank initiated coverage on Bionano Genomics Inc (NASDAQ:BNGO). The price target seems to have been set at $4.00 for Bionano Genomics. In the third quarter, Bionano Genomics showed an EPS of $0.11, compared to $0.07 from the year-ago quarter. The current stock performance of Bionano Genomics shows a 52-week-high of $4.35 and a 52-week-low of $1.16. Moreover, at the end of the last trading period, the closing price was at $1.49.

With a Sector Outperform rating, Scotiabank initiated coverage on Castle Biosciences Inc (NASDAQ:CSTL). The price target seems to have been set at $54.00 for Castle Biosciences. In the third quarter, Castle Biosciences showed an EPS of $0.77, compared to $0.44 from the year-ago quarter. At the moment, the stock has a 52-week-high of $48.40 and a 52-week-low of $15.58. Castle Biosciences closed at $23.14 at the end of the last trading period.

With a Sector Outperform rating, Scotiabank initiated coverage on Pacific Biosciences of California Inc (NASDAQ:PACB). The price target seems to have been set at $12.00 for Pacific Biosciences. Pacific Biosciences earned $0.32 in the third quarter, compared to $0.23 in the year-ago quarter. The current stock performance of Pacific Biosciences shows a 52-week-high of $21.01 and a 52-week-low of $3.85. Moreover, at the end of the last trading period, the closing price was at $8.27.

Scotiabank initiated coverage on Olink Holding AB (NASDAQ:OLK) with a Sector Outperform rating. The price target for Olink Holding is set to $27.00. In the third quarter, Olink Holding showed an EPS of $0.01, compared to $0.05 from the year-ago quarter. The current stock performance of Olink Holding shows a 52-week-high of $26.47 and a 52-week-low of $8.39. Moreover, at the end of the last trading period, the closing price was at $21.26.

DA Davidson initiated coverage on Microsoft Corp (NASDAQ:MSFT) with a Buy rating. The price target for Microsoft is set to $270.00. In the first quarter, Microsoft showed an EPS of $2.35, compared to $2.27 from the year-ago quarter. The current stock performance of Microsoft shows a 52-week-high of $335.20 and a 52-week-low of $213.43. Moreover, at the end of the last trading period, the closing price was at $229.10.

Benchmark initiated coverage on AppLovin Corp (NASDAQ:APP) with a Sell rating. The price target for AppLovin is set to $7.00. AppLovin earned $0.06 in the third quarter, compared to $0.00 in the year-ago quarter. At the moment, the stock has a 52-week-high of $95.31 and a 52-week-low of $9.14. AppLovin closed at $10.90 at the end of the last trading period.

EF Hutton initiated coverage on Adaptimmune Therapeutics PLC (NASDAQ:ADAP) with a Buy rating. The price target for Adaptimmune Therapeutics is set to $10.00. In the third quarter, Adaptimmune Therapeutics showed an EPS of $0.24, compared to $0.30 from the year-ago quarter. At the moment, the stock has a 52-week-high of $4.12 and a 52-week-low of $1.01. Adaptimmune Therapeutics closed at $1.78 at the end of the last trading period.

With a Buy rating, EF Hutton initiated coverage on Century Therapeutics Inc (NASDAQ:IPSC). The price target seems to have been set at $18.00 for Century Therapeutics. For the third quarter, Century Therapeutics had an EPS of $0.53, compared to year-ago quarter EPS of $0.48. The current stock performance of Century Therapeutics shows a 52-week-high of $16.83 and a 52-week-low of $4.69. Moreover, at the end of the last trading period, the closing price was at $4.97.

EF Hutton initiated coverage on Rain Oncology Inc (NASDAQ:RAIN) with a Buy rating. The price target for Rain Oncology is set to $16.00. Rain Oncology earned $0.68 in the third quarter, compared to $0.70 in the year-ago quarter. At the moment, the stock has a 52-week-high of $14.03 and a 52-week-low of $2.15. Rain Oncology closed at $8.00 at the end of the last trading period.

With a Buy rating, EF Hutton initiated coverage on BioAtla Inc (NASDAQ:BCAB). The price target seems to have been set at $25.00 for BioAtla. For the third quarter, BioAtla had an EPS of $0.69, compared to year-ago quarter EPS of $0.68. The current stock performance of BioAtla shows a 52-week-high of $19.29 and a 52-week-low of $2.01. Moreover, at the end of the last trading period, the closing price was at $8.07.

With a Buy rating, EF Hutton initiated coverage on Atara Biotherapeutics Inc (NASDAQ:ATRA). The price target seems to have been set at $25.00 for Atara Biotherapeutics. Atara Biotherapeutics earned $0.82 in the third quarter, compared to $0.90 in the year-ago quarter. The current stock performance of Atara Biotherapeutics shows a 52-week-high of $16.91 and a 52-week-low of $2.83. Moreover, at the end of the last trading period, the closing price was at $3.35.

EF Hutton initiated coverage on Merus NV (NASDAQ:MRUS) with a Buy rating. The price target for Merus is set to $35.00. Merus earned $0.53 in the third quarter, compared to $0.39 in the year-ago quarter. At the moment, the stock has a 52-week-high of $30.94 and a 52-week-low of $12.03. Merus closed at $15.87 at the end of the last trading period.

With a Buy rating, EF Hutton initiated coverage on Allogene Therapeutics Inc (NASDAQ:ALLO). The price target seems to have been set at $15.00 for Allogene Therapeutics. For the third quarter, Allogene Therapeutics had an EPS of $0.58, compared to year-ago quarter EPS of $0.57. At the moment, the stock has a 52-week-high of $17.49 and a 52-week-low of $5.55. Allogene Therapeutics closed at $5.80 at the end of the last trading period.

EF Hutton initiated coverage on Bicycle Therapeutics PLC (NASDAQ:BCYC) with a Buy rating. The price target for Bicycle Therapeutics is set to $55.00. In the third quarter, Bicycle Therapeutics showed an EPS of $0.96, compared to $0.59 from the year-ago quarter. At the moment, the stock has a 52-week-high of $59.22 and a 52-week-low of $12.08. Bicycle Therapeutics closed at $30.80 at the end of the last trading period.

With a Buy rating, EF Hutton initiated coverage on G1 Therapeutics Inc (NASDAQ:GTHX). The price target seems to have been set at $35.00 for G1 Therapeutics. For the third quarter, G1 Therapeutics had an EPS of $0.59, compared to year-ago quarter EPS of $1.00. The stock has a 52-week-high of $17.49 and a 52-week-low of $3.84. At the end of the last trading period, G1 Therapeutics closed at $5.45.

With a Buy rating, EF Hutton initiated coverage on Sinovac Biotech Ltd (NASDAQ:SVA). The price target seems to have been set at $5.00 for Sinovac Biotech. None

With a Buy rating, EF Hutton initiated coverage on Genenta Science SPA (NASDAQ:GNTA). The price target seems to have been set at $15.00 for Genenta Science.

With a Buy rating, EF Hutton initiated coverage on Aravive Inc (NASDAQ:ARAV). The price target seems to have been set at $10.00 for Aravive. For the third quarter, Aravive had an EPS of $0.51, compared to year-ago quarter EPS of $0.53. The current stock performance of Aravive shows a 52-week-high of $2.84 and a 52-week-low of $0.58. Moreover, at the end of the last trading period, the closing price was at $1.53.

EF Hutton initiated coverage on Compugen Ltd (NASDAQ:CGEN) with a Buy rating. The price target for Compugen is set to $13.00. For the third quarter, Compugen had an EPS of $0.14, compared to year-ago quarter EPS of $0.07. The current stock performance of Compugen shows a 52-week-high of $4.64 and a 52-week-low of $0.51. Moreover, at the end of the last trading period, the closing price was at $0.76.

With a Buy rating, EF Hutton initiated coverage on Replimune Group Inc (NASDAQ:REPL). The price target seems to have been set at $60.00 for Replimune Group. Replimune Group earned $0.79 in the second quarter, compared to $0.56 in the year-ago quarter. At the moment, the stock has a 52-week-high of $30.89 and a 52-week-low of $13.05. Replimune Group closed at $26.25 at the end of the last trading period.

EF Hutton initiated coverage on Fate Therapeutics Inc (NASDAQ:FATE) with a Buy rating. The price target for Fate Therapeutics is set to $16.00. For the third quarter, Fate Therapeutics had an EPS of $0.86, compared to year-ago quarter EPS of $0.45. At the moment, the stock has a 52-week-high of $59.84 and a 52-week-low of $9.56. Fate Therapeutics closed at $11.12 at the end of the last trading period.

EF Hutton initiated coverage on CRISPR Therapeutics AG (NASDAQ:CRSP) with a Buy rating. The price target for CRISPR Therapeutics is set to $75.00. CRISPR Therapeutics earned $2.24 in the third quarter, compared to $1.67 in the year-ago quarter. The current stock performance of CRISPR Therapeutics shows a 52-week-high of $86.95 and a 52-week-low of $38.94. Moreover, at the end of the last trading period, the closing price was at $45.00.

EF Hutton initiated coverage on TCR2 Therapeutics Inc (NASDAQ:TCRR) with a Hold rating. The price target for TCR2 Therapeutics is set to $2.00. TCR2 Therapeutics earned $0.79 in the third quarter, compared to $0.69 in the year-ago quarter. The current stock performance of TCR2 Therapeutics shows a 52-week-high of $4.71 and a 52-week-low of $0.82. Moreover, at the end of the last trading period, the closing price was at $1.05.

With a Hold rating, EF Hutton initiated coverage on GT Biopharma Inc (NASDAQ:GTBP). The price target seems to have been set at $2.00 for GT Biopharma. GT Biopharma earned $0.22 in the third quarter, compared to $0.17 in the year-ago quarter. The current stock performance of GT Biopharma shows a 52-week-high of $3.74 and a 52-week-low of $0.88. Moreover, at the end of the last trading period, the closing price was at $1.02.

With a Buy rating, EF Hutton initiated coverage on Atreca Inc (NASDAQ:BCEL). The price target seems to have been set at $10.00 for Atreca. Atreca earned $0.60 in the third quarter, compared to $0.74 in the year-ago quarter. The stock has a 52-week-high of $5.36 and a 52-week-low of $0.76. At the end of the last trading period, Atreca closed at $1.02.

With a Buy rating, EF Hutton initiated coverage on Apexigen Inc (NASDAQ:APGN). The price target seems to have been set at $8.00 for Apexigen. At the moment, the stock has a 52-week-high of $31.35 and a 52-week-low of $0.61. Apexigen closed at $0.67 at the end of the last trading period.

See all analyst ratings initiations.